Vivo Ventures Fund V, L.P.'s Net Worth

$NaN

Estimate Recalculated Jul 3, 2024 05:03PM EST

Who is Vivo Ventures Fund V, L.P.?

Vivo Ventures Fund V, L.P. has an estimated net worth of $NaN. This is based on reported shares across multiple companies, which include SOLENO THERAPEUTICS INC, Sagent Pharmaceuticals, Inc., and MEI Pharma, Inc..

SEC CIK

Vivo Ventures Fund V, L.P.'s CIK is 0001398937

Past Insider Trading and Trends

2014 was Vivo Ventures Fund V, L.P.'s most active year for acquiring shares with 62 total transactions. Vivo Ventures Fund V, L.P.'s most active month to acquire stocks was the month of October. 2014 was Vivo Ventures Fund V, L.P.'s most active year for disposing of shares, totalling 32 transactions. Vivo Ventures Fund V, L.P.'s most active month to dispose stocks was the month of October. 2017 saw Vivo Ventures Fund V, L.P. paying a total of $3,354,039.46 for 9,127,014 shares, this is the most they've acquired in one year. In 2016 Vivo Ventures Fund V, L.P. cashed out on 3,115,769 shares for a total of $65,576,534.75, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

SOLENO THERAPEUTICS INC (SLNO) Snapshot price: $46.745

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.93%
-34.03K
$1.62
-$55,125.36
3.63M
Dec 2
Form 4
-0.49%
-18.07K
$1.55
-$27,948.99
3.67M
Nov 26 - Nov 27
Form 4
-1.65%
-61.67K
$1.55
-$95,737.80
3.69M
Nov 21 - Nov 25
Form 4
-1.10%
-41.63K
$1.55
-$64,524.95
3.75M
Nov 18 - Nov 20
Form 4
-2.50%
-97.02K
$1.55
-$150,387.20
3.79M
Nov 13 - Nov 15
Form 4
-0.23%
-8.76K
$1.55
-$13,584.20
3.89M
Nov 5
Form 4
-7.91%
-334.42K
$1.57
-$524,786.81
3.89M
Oct 31 - Nov 4
Form 4
-0.72%
-30.55K
$1.59
-$48,513.95
4.23M
Oct 24 - Oct 28
Form 4
+4.12%
326.15K
$3.40
$1,108,906.60
8.25M
Mar 7 - May 14
Form 4
+38.11%
1.09M
$1.84
$1,999,996.90
3.93M
Dec 15
Form 4
+103.35%
7.24M
$0.96
—
14.24M
Mar 7
Form 4
+1.98%
136.22K
—
—
7M
Feb 8
Form 4
+5.11%
333.79K
—
—
6.87M
Jan 8
Form 4
+33.61%
1.64M
—
—
6.53M
Nov 19
Form 4
+27.39%
1.05M
—
—
4.89M
Aug 14
Form 4
+26.18%
796.46K
—
—
3.84M
Aug 12
Form 4
∞
-7.83M
—
—
18.57M
Nov 18
Form 4
∞
-7.83M
—
—
18.57M
Nov 18
Form 3
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

Sagent Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.01M
$21.75
-$65,549,367.00
0
Aug 29
Form 4
-0.07%
-2.00K
$13.55
-$27,167.75
3.01M
Apr 21
Form 4
-5.67%
-603.18K
$16.21
-$9,484,667.65
10.03M
Nov 2 - Nov 4
Form 4
-12.96%
-539.02K
$21.25
-$11,454,111.25
3.62M
Sep 16
Form 3
—
0
—
—
0
No matching records found

MEI Pharma, Inc. (MEIP) Snapshot price: $4.7

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-8.82%
-17.41K
$8.21
-$142,974.02
180.01K
Oct 25 - Oct 29
Form 4
-14.62%
-33.79K
$10.16
-$343,501.43
197.42K
Oct 1 - Oct 2
Form 4
-0.18%
-426.00
$7.58
-$3,228.10
231.22K
Jun 28
Form 4
-5.59%
-13.73K
$7.80
-$107,070.60
231.64K
Jun 11
Form 4
-0.41%
-1.01K
$9.07
-$9,174.29
245.37K
May 16
Form 3
—
0
—
—
0
No matching records found